Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19

Anti-Interleukin-8 (Anti-IL-8) for Cancer Patients With COVID-19
Conditions:   Solid Tumor;   Sars-CoV2;   Hematological Malignancy
Intervention:   Drug: BMS-986253
Sponsors:   Matthew Dallos;   Bristol-Myers Squibb

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 21, 2020 / by / in